NASDAQ: CGONCg Oncology Inc Stock Ownership - Who owns Cg Oncology?
Insider buying vs selling
Have Cg Oncology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Mulay | Director | 2025-09-05 | 27,015 | $0.60 | $16.21kBuy |
| James Mulay | Director | 2025-09-05 | 12,342 | $30.47 | $376.06kSell |
| James Mulay | Director | 2025-09-05 | 4,095 | $31.42 | $128.66kSell |
| James Mulay | Director | 2025-09-05 | 7,465 | $32.64 | $243.66kSell |
| James Mulay | Director | 2025-09-05 | 3,113 | $33.22 | $103.41kSell |
| Hong Fang Song | Director | 2025-09-03 | 100 | $28.99 | $2.90kSell |
| Leonard E. Post | Director | 2025-09-03 | 1,000 | $28.00 | $28.00kSell |
| Leonard E. Post | Director | 2025-09-03 | 1,000 | $0.60 | $600.00Buy |
| Hong Fang Song | Director | 2025-09-03 | 69,695 | $27.60 | $1.92MSell |
| Hong Fang Song | Director | 2025-09-03 | 30,105 | $28.24 | $850.17kSell |
CGON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CGON insiders and whales buy or sell their stock.
CGON Shareholders
What type of owners hold Cg Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Hong Fang Song | 9.23% | 7,039,077 | $234.68M | Insider |
| Decheng Capital LLC | 8.36% | 6,371,669 | $212.43M | Institution |
| Vanguard Group Inc | 7.75% | 5,906,511 | $196.92M | Institution |
| Decheng Capital Global Life Sciences Fund IV LP | 7.03% | 5,358,810 | $178.66M | Insider |
| Blackrock Inc | 5.85% | 4,456,423 | $148.58M | Institution |
| Fmr LLC | 5.06% | 3,856,261 | $128.57M | Institution |
| Tcg Crossover Management LLC | 4.81% | 3,670,206 | $122.36M | Institution |
| Braidwell LP | 4.31% | 3,283,317 | $109.47M | Institution |
| Kynam Capital Management LP | 3.22% | 2,457,667 | $81.94M | Institution |
| Ubs Group Ag | 2.92% | 2,229,245 | $74.32M | Institution |
CGON vs Biotech Stocks
Cg Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.